HDL376 is a scavenger receptor class B type I (SR-BI) inhibitor. HDL376 directly inhibits SR-BI-mediated lipid transport in cells and in liposomes reconstituted with purified SR-BI (IC50 = 0.22 μM). HDL376 can be used for the research of atherosclerotic coronary artery disease[1].

HDLBP Human Pre-designed siRNA Set A contains three designed siRNAs for HDLBP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDX Human Pre-designed siRNA Set A contains three designed siRNAs for HDX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HEATR1 Human Pre-designed siRNA Set A contains three designed siRNAs for HEATR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HEATR3 Human Pre-designed siRNA Set A contains three designed siRNAs for HEATR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HEATR5B Human Pre-designed siRNA Set A contains three designed siRNAs for HEATR5B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HEBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for HEBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HEBP2 Human Pre-designed siRNA Set A contains three designed siRNAs for HEBP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HECA Human Pre-designed siRNA Set A contains three designed siRNAs for HECA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HECTD1 Human Pre-designed siRNA Set A contains three designed siRNAs for HECTD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HECTD2 Human Pre-designed siRNA Set A contains three designed siRNAs for HECTD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HECTD3 Human Pre-designed siRNA Set A contains three designed siRNAs for HECTD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HECTD4 Human Pre-designed siRNA Set A contains three designed siRNAs for HECTD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HECW1 Human Pre-designed siRNA Set A contains three designed siRNAs for HECW1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HECW2 Human Pre-designed siRNA Set A contains three designed siRNAs for HECW2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hedgehog IN-1 (Compound 7d) is an inhibitor for Hedgehog protein with IC50 of 70 nM[1].

Hedgehog IN-6 (Compound Q29) is a Hedgehog (Hh) inhibitor that can be used in cancer research. Hedgehog IN-6 inhibits the hedgehog (Hh) pathway by binding to the cysteine-rich domain (CRD) of Smoothened (Smo) and blocking its cholesterization[1].

HEG1 Human Pre-designed siRNA Set A contains three designed siRNAs for HEG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Heilaohuguosu G (compound 7) is a cyclolignan with hepatoprotective activity. Heilaohuguosu G against APAP toxicity with cell survival rates at 10 μM of 45.7% in HepG-2 cells[1].

HELB Human Pre-designed siRNA Set A contains three designed siRNAs for HELB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HELQ Human Pre-designed siRNA Set A contains three designed siRNAs for HELQ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HELT Human Pre-designed siRNA Set A contains three designed siRNAs for HELT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HELZ Human Pre-designed siRNA Set A contains three designed siRNAs for HELZ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HELZ2 Human Pre-designed siRNA Set A contains three designed siRNAs for HELZ2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HEMGN Human Pre-designed siRNA Set A contains three designed siRNAs for HEMGN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hemocoagulase, deinagkistrodonacutus is a hemocoagulase isolated and purified from the venom of agkistrodon agkistrodon to prevent bleeding after surgery[1].

Hemoglobin 64-76 is a T cell inducing determinant, that binds to two different MHC class II molecules in distinct registers and lengths[1].

Heneicosanoyl-CoA is a substrate of Very long-chain acyl-CoA dehydrogenase (VLCAD) in the anaerobic electron transfer flavoprotein (ETF) assay[1].

HENMT1 Human Pre-designed siRNA Set A contains three designed siRNAs for HENMT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hentriacontane is a long-chain alkane. Hentriacontane exerts anti-inflammatory effects by inhibiting the NF-κB pathway. Hentriacontane has anti-inflammatory, antitumor and antibacterial activities[1].

HEPACAM Human Pre-designed siRNA Set A contains three designed siRNAs for HEPACAM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HEPACAM2 Human Pre-designed siRNA Set A contains three designed siRNAs for HEPACAM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Heparin calcium (MW 15000-19000) is an anticoagulant which binds reversibly to antithrombin III (ATIII) to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors IX, X, XI, and XII and prevents the transformation of fibrinogen to fibrin[1][2].

Heparin (Nadroparin) calcium (MW 3600-5000) is an anticoagulant which binds reversibly to antithrombin III (ATIII) to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors IX, X, XI, and XII and prevents the transformation of fibrinogen to fibrin[1][2].

Heparin Methacrylate (HepMA) is methacrylated heparin and is an ideal tissue engineering scaffold material and 3D printing bioink[1].

HEPH Human Pre-designed siRNA Set A contains three designed siRNAs for HEPH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HEPHL1 Human Pre-designed siRNA Set A contains three designed siRNAs for HEPHL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Heptadecanoyl ethanolamide is an endogenous cannabinoid. Heptadecanoyl ethanolamide is a synthetic analog of PEA which incorporates an odd-numbered (17-carbon) fatty acid chain[1].

HER2-IN-15 (Compound 1) is an inhibitor for HER2, which inhibits the Her YVMA exon 20 insertion mutation (HER2 YVMA) with an IC50

HER2-IN-16 (Compound 14) is an inhibitor for HER2, which inhibits the Her YVMA exon 20 insertion mutation (HER2 YVMA) with an IC50

HER2-IN-17 (Compound 2) is an inhibitor for HER2, which inhibits the Her YVMA exon 20 insertion mutation (HER2 YVMA) with an IC50

HER2-IN-18 is a HER2 inhibitor, with an IC50 less than 200 nM for HER-YVMA and HER-WT. HER2-IN-18 can be used for cancer research[1].

HER2-IN-19 (Compound 10e) is a potent inhibitor of HER2 and EGFR with IC50 values of 0.87 respectively and 3.5 nM. HER2-IN-19 has potent inhibitory activity against tumor cells, IC50NCI-N87 = 1.63 nM, IC50BT474= 15.17 nM, IC50BaF3-HER2YVMA = 1.49 nM[1].

Herbicidal agent 2 (compound 8d), a herbicide, is a protoporphyrinogen oxidase (PPO) inhibitor. Herbicidal agent 2 exhibits herbicidal activities against broadleaf and monocotyledon weeds[1].

Herbicidal agent 3 (compound 7A) shows herbicidal activity against Digitaria sanguinalis and Amaranthus retroflexus at a dosage of 90 g ai/ha. Herbicidal agent 3 inhibites Setaria viridis TKL (SvTKL) enzyme activity, with the IC50 of 0.740 mg/L[1].